This paper evaluates and quantifies the short-term impact of the coronavirus disease of 2019 (COVID-19) on stock market performance in thirteen (13) African countries, using daily time series stock market data spanning 1st October 2019 to 30th June 2020. We employ a novel Bayesian structural time series approach (a state-space model) to estimate the relative effects of the COVID-19 pandemic on stock market performance in those countries. Generally, our Bayesian posterior estimates show that, in relative terms, stock market performances in Africa have significantly reduced during and after the occurrence of the COVID-19, usually between -2.7 % and -21 %. At the heterogeneous level, we find that 10 countries have their stock markets significantly and adversely affected by the COVID-19, whereas the remaining 3 countries see no significant impact (or a rather short-lived negative significant impact) of the COVID-19 pandemic on their stock markets. We find that, within our sample period, there is almost no chance that the COVID-19 pandemic would have positive effects on the stock market performance in Africa. Our findings contribute to the discussion and research on the economic impact of the COVID-19 pandemic by providing empirical evidence that the pandemic has restrictive effects on stock market performance in African economies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722498 | PMC |
http://dx.doi.org/10.1016/j.jeconbus.2020.105968 | DOI Listing |
Lancet Diabetes Endocrinol
January 2025
Division of Diabetes & Nutritional Sciences, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK; Catholic University of the Sacred Heart, Rome, Italy; University Polyclinic Foundation Agostino Gemelli IRCCS, Rome, Italy.
Evid Based Nurs
January 2025
New York Medical College, Valhalla, New York, USA
Target Oncol
January 2025
Hematology-Oncology Service, Department of Medicine, Centre hospitalier de l'Université de Montréal (CHUM), 1000, rue Saint-Denis, Montreal, QC, Canada.
Background: BERIL-1 was a randomized phase 2 study that studied paclitaxel with either buparlisib, a pan-class I PIK3 inhibitor, or placebo in patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC). Considering the therapeutic paradigm shift with immune checkpoint inhibitors (ICIs) now approved in the first-line setting, we present an updated immunogenomic analysis of patients enrolled in BERIL-1, including patients with immune-infiltrated tumors.
Objective: The objective of this study was to identify biomarkers predictive of treatment efficacy in the context of the post-ICI therapeutic landscape.
BMJ Open
December 2024
Perinatal HIV Research Unit (PHRU), University of the Witwatersrand Johannesburg, Johannesburg, Gauteng, South Africa.
Purpose: In the setting of an established childhood pneumococcal vaccination programme with immediate initiation and treatment of antiretroviral therapy (ART) for people living with HIV (PLWH), the risk of adult pneumococcal community-acquired pneumonia (CAP) is not recently described. We aimed to investigate CAP incidence, recurrence, mortality, risk factors and microbiology before and during the COVID-19 pandemic.
Participants: Adults aged ≥18 years were enrolled in three South African provinces from March 2019 to October 2021, with a brief halt during the initial COVID-19 lockdown.
PLoS One
January 2025
Harvard extension school, Harvard University, Boston, Massachusetts, United States of America.
To address the limitations of existing stock price prediction models in handling real-time data streams-such as poor scalability, declining predictive performance due to dynamic changes in data distribution, and difficulties in accurately forecasting non-stationary stock prices-this paper proposes an incremental learning-based enhanced Transformer framework (IL-ETransformer) for online stock price prediction. This method leverages a multi-head self-attention mechanism to deeply explore the complex temporal dependencies between stock prices and feature factors. Additionally, a continual normalization mechanism is employed to stabilize the data stream, enhancing the model's adaptability to dynamic changes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!